Comparative analysis of highly defined proteases for the isolation of adipose tissue-derived stem cells

Regenerative Medicine

Volumn 3, Issue 5, 2008, Pages 705-715

  Pilgaard, Linda ^a   Lund, Pia ^a   Fink, Trine ^b   Zachar, Vladimir ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Adipose derived stem cells; Collagenase; Colony forming unit; Enzymatic dissociation; Protease

Indexed keywords

BLENDZYME 1; BLENDZYME 2; BLENDZYME 3; BLENDZYME 4; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGENASE; LIBERASE H1; PEPTIDE HYDROLASE; PROTEINASE; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ABDOMINAL FAT ASPIRATION BIOPSY; ADIPOSE TISSUE CELL; ADULT; AMINO ACID COMPOSITION; ARTICLE; BODY MASS; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; ADIPOSE TISSUE; BIOLOGICAL MODEL; BIOSYNTHESIS; CYTOLOGY; FIBROBLAST; METABOLISM; METHODOLOGY; MIDDLE AGED; REGENERATIVE MEDICINE;

ADIPOSE TISSUE; ADULT; ANTIGENS, CD34; ANTIGENS, CD45; ANTIGENS, THY-1; COLLAGENASES; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING;

EID: 55949128313     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.5.705     Document Type: Article

References (26)

1. Wollert KC, Meyer GP Lotz J et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004).
2. Horwitz EM, Prockop DJ, Fitzpatrick LA et al.: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309-313 (1999).
3. Aviles FF, San Roman JA, Garcia Frade J et al.: Intracoronary stem cell transplantation in acute myocardial infarction. Rev. Esp. Cardiol. 57, 201-208 (2004).
4. Kuroda R, Ishida K, Matsumoto T et al: Treatment of a full-thickness; articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr. Cartil. 15, 226-231 (2007).
5. De Ugarte DA, Morizono K, Elbarbary A et al.: Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174, 101-109 (2003).
6. Georges P, Muirhead RP, Williams L et al.: Comparison of size, viability, and function of fetal pig islet-like cell clusters after digestion using collagenase or liberase. Cell Transplant. 11, 539-545 (2002).
7. Wang H, Van Blitterswijk CA, Bertrand-De Haas M, Schuurman AH, Lamme EN: Improved enzymatic isolation of fibroblasts for the creation of autologous skin substitutes. In Vitro Cell Dev. Biol. Anim. 40, 268-277 (2004).
8. Williams SK, McKenney S, Jarrell BE: Collagenase lot selection and purification for adipose tissue digestion. Cell Transplant. 4, 281-289 (1995).
9. Hayman DM, Blumberg TJ, Scott CC, Athanasiou KA: The effects of isolation on chondrocyte gene expression. Tissue Eng. 12, 2573-2581 (2006).
10. Varma MJ, Breuls RG, Schouten TE et al.: Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev. 16, 91-104 (2007).
11. Mitchell JB, McIntosh K, Zvonic S et al.: Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24, 376-385 (2006).
12. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ: Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530-541 (2002).
13. Kin T, Johnson PR, Shapiro AM, Lakey JR: Factors influencing the collagenase digestion phase of human islet isolation. Transplantation 83, 7-12 (2007).
14. Zuk PA, Zhu M, Mizuno H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tisue Eng. 7, 211-228 (2001).
15. Guilak F, Lott KE, Awad HA et al.: Clonal analysis of the differentiation potential of human ASCs. J. Cell. Physiol. 206(l), 229-237 (2005).
16. Meyerrose TE, De Ugarte DA. Hofling AA et al.: In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25(1), 220-227 (2007).
17. Yoshimura K, Shigeura T, Matsumoto D et al.: Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J. Cell. Physiol. 208, 64-76 (2006).
18. Aust L, Devlin B, Foster SJ et al.: Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6, 7-14 (2004).
19. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M et al.: Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166-177 (2006).
20. Bellows CG, Aubin JE: Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev. Biol. 133, 8-13 (1989).
21. Wu X, Peters JM, Gonzalez FJ, Prasad HS, Rohrer MD, Gimble JM: Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-α-null mice. Bone 26, 21-26 (2000).
22. Castro-Malaspina, H, Gay RE, Resnick G et al.: Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56, 289-301 (1980).
23. Sen A, Lea-Currie YR, Sujkowska D et al.: Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J. Cell. Biochem. 81, 312-319 (2001).
24. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM: Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189, 64-63 (2001).
25. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC: Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23, 412-423 (2005).
26. Daniels E: Cytori Therapeutics, Inc. Regen. Med. 2(3), 317-320 (2007).